Keratoconus and Corneal Cross-Linking

​

What is Keratoconus?

Keratoconus is an eye condition where the clear front surface of the eye (the cornea) becomes thinner and gradually bulges outward into a cone shape.

 

 

 

 

 

 

 

 

 

 

Because the cornea helps focus light, this change can cause:

• Blurred or distorted vision

• Increasing short-sightedness or astigmatism

• Sensitivity to light

• Frequent changes in glasses or contact lens prescriptions

Keratoconus often starts in the teenage years or early adulthood. For many people, the condition slowly gets worse over time.

 

What is Corneal Cross-Linking (CXL)?

Corneal cross-linking is a treatment designed to strengthen the cornea and slow or stop keratoconus from getting worse.

During the procedure:

1. Vitamin B2 drops (riboflavin) are placed onto the cornea.

2. A special UV light shines on the cornea for a set period.

3. The interaction between the drops and the light creates new “links” in the corneal tissue, making it firmer and more stable.

This treatment is usually done once and typically takes about 60–90 minutes.

 

Benefits of Corneal Cross-Linking

• Slows or stops progression: The main benefit is preventing further worsening of keratoconus. 

  • According to the Cleveland Clinic, success rates (in terms of halting keratoconus progression) are around 95% in many studies. Cleveland Clinic

  • The Keratoconus Australia patient brochure states that CXL “is successful in stopping keratoconus getting worse in more than 9 out of 10 people.” keratoconus.org.au+1

  • A 5-year study from the “Save Sight” Keratoconus Registry found that most patients remained stable at 5 years

  • In a study of advanced keratoconus (Kmax > 58 D), progression was halted in 96.6% of eyes at 2 years. PubMed

• Can reduce the need for future surgery: By stabilizing the cornea, CXL can lower the chances of needing a corneal transplant later.

• Safe and well-studied: Most patients recover well with long-term stability.

• May improve vision in some cases: Some people notice slight improvements in shape and clarity over time, though this is not guaranteed.

 

Risks and Side Effects

Most side effects are temporary, but it’s important to understand the possibilities:

Common (usually temporary):

• Eye discomfort or pain for several days

• Light sensitivity

• Redness and watering

• Blurred vision during healing

• Feeling like something is in the eye

Less common:

• Infection (rare but serious)

• Delayed healing of the corneal surface

• Haze or scarring

• Reduced clarity of vision during the early healing period

• Need for retreatment if the keratoconus continues to progress

Your doctor will discuss whether the “epithelium-off” or “epithelium-on” technique is recommended, as risks and healing times can differ.

​

What to Expect After the Procedure

• A protective contact lens may be placed on the eye for a few days.

• You will be given eye drops to prevent infection and reduce inflammation.

• Vision may be blurry for several weeks and gradually improve.

• Most people return to normal activities within a week, but healing continues for several months.

• Follow-up visits are important to monitor your recovery.

• ​

Is Cross-Linking Right for You?

CXL is recommended if:

• Your keratoconus is getting worse, or

• You are at high risk of progression (common in younger patients)

It is less helpful if keratoconus is already advanced or if the cornea is extremely thin; in these situations, other treatments may be needed.

​

When to Seek Help After Treatment

Contact your eye clinic immediately if you experience:

• Severe or increasing pain

• Sudden vision loss

• Increasing redness or discharge

• Symptoms that worry you

Bottom Line

• Why do it? To stop keratoconus from getting worse. It’s currently the only widely used treatment that can do this reliably.

• How successful? Very high for stabilisation—typically over 90%–95% in many studies.

• Vision change? Some flattening and modest visual improvement in many, but not a guarantee, and you will often still need corrective lenses.

• Is it “safe enough”? Generally yes, especially compared to the risk of keratoconus progression, though there are risks that need to be carefully weighed

Corneal cross-linking is the only treatment proven to slow or stop the progression of keratoconus. Although it has some risks and requires healing time, it is generally safe and helps protect long-term vision.

​